Cargando…
Vitiligo - Part 2 - classification, histopathology and treatment*
In an unprecedented effort in the field of vitiligo, a global consensus resulted on a suggested new classification protocol for the disease. The main histopathological finding in vitiligo is the total absence of functioning melanocytes in the lesions, while the inflammatory cells most commonly found...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Dermatologia
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155957/ https://www.ncbi.nlm.nih.gov/pubmed/25184918 http://dx.doi.org/10.1590/abd1806-4841.20142717 |
_version_ | 1782333661731880960 |
---|---|
author | Reichert Faria, Adriane Tarlé, Roberto Gomes Dellatorre, Gerson Mira, Marcelo Távora Silva de Castro, Caio Cesar |
author_facet | Reichert Faria, Adriane Tarlé, Roberto Gomes Dellatorre, Gerson Mira, Marcelo Távora Silva de Castro, Caio Cesar |
author_sort | Reichert Faria, Adriane |
collection | PubMed |
description | In an unprecedented effort in the field of vitiligo, a global consensus resulted on a suggested new classification protocol for the disease. The main histopathological finding in vitiligo is the total absence of functioning melanocytes in the lesions, while the inflammatory cells most commonly found on the edges of the lesions are CD4+ and CD8+ T lymphocytes. Physical and pharmacological treatment strategies aim to control the autoimmune damage and stimulate melanocyte migration from the unaffected edges of lesions and the outer hair follicle root sheath to the affected skin; moreover, surgical treatments can be combined with topical and physical treatments. |
format | Online Article Text |
id | pubmed-4155957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Sociedade Brasileira de Dermatologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-41559572014-09-09 Vitiligo - Part 2 - classification, histopathology and treatment* Reichert Faria, Adriane Tarlé, Roberto Gomes Dellatorre, Gerson Mira, Marcelo Távora Silva de Castro, Caio Cesar An Bras Dermatol Review In an unprecedented effort in the field of vitiligo, a global consensus resulted on a suggested new classification protocol for the disease. The main histopathological finding in vitiligo is the total absence of functioning melanocytes in the lesions, while the inflammatory cells most commonly found on the edges of the lesions are CD4+ and CD8+ T lymphocytes. Physical and pharmacological treatment strategies aim to control the autoimmune damage and stimulate melanocyte migration from the unaffected edges of lesions and the outer hair follicle root sheath to the affected skin; moreover, surgical treatments can be combined with topical and physical treatments. Sociedade Brasileira de Dermatologia 2014 /pmc/articles/PMC4155957/ /pubmed/25184918 http://dx.doi.org/10.1590/abd1806-4841.20142717 Text en ©2014 by Anais Brasileiros de Dermatologia http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Reichert Faria, Adriane Tarlé, Roberto Gomes Dellatorre, Gerson Mira, Marcelo Távora Silva de Castro, Caio Cesar Vitiligo - Part 2 - classification, histopathology and treatment* |
title | Vitiligo - Part 2 - classification, histopathology and treatment*
|
title_full | Vitiligo - Part 2 - classification, histopathology and treatment*
|
title_fullStr | Vitiligo - Part 2 - classification, histopathology and treatment*
|
title_full_unstemmed | Vitiligo - Part 2 - classification, histopathology and treatment*
|
title_short | Vitiligo - Part 2 - classification, histopathology and treatment*
|
title_sort | vitiligo - part 2 - classification, histopathology and treatment* |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155957/ https://www.ncbi.nlm.nih.gov/pubmed/25184918 http://dx.doi.org/10.1590/abd1806-4841.20142717 |
work_keys_str_mv | AT reichertfariaadriane vitiligopart2classificationhistopathologyandtreatment AT tarlerobertogomes vitiligopart2classificationhistopathologyandtreatment AT dellatorregerson vitiligopart2classificationhistopathologyandtreatment AT miramarcelotavora vitiligopart2classificationhistopathologyandtreatment AT silvadecastrocaiocesar vitiligopart2classificationhistopathologyandtreatment |